Brief: Alimera Sciences Announces Launch Of Iluvien For Uveitis In Spain
07/02/2022 13:07
Feb 7 (Reuters) - Alimera Sciences Inc ALIM.O :
* ALIMERA SCIENCES ANNOUNCES LAUNCH OF ILUVIEN® FOR UVEITIS
IN
SPAIN
* ALIMERA SCIENCES-ALIMERA SCIENCES EUROPE WILL LAUNCH
ILUVIEN FOR
NON-INFECTIOUS POSTERIOR UVEITIS IN SPAIN, THROUGH DISTRIBUTION
PARTNER, BRILL PHARMA
* ALIMERA - BRILL RECEIVED POSITIVE RESOLUTION FOR PRICING
AND
REIMBURSEMENT APPROVAL FOR ILUVIEN
Source text for Eikon: ID:nGNX1LJTC6
Further company coverage: ALIM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger